Your browser doesn't support javascript.
loading
A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.
Vize, Colin J; Kim, Stella K; Matthews, Tim; Macsai, Marian; Merrell, Ryan; Hsu, Sigmund; Kundu, Madan Gopal; Yoon, Jennifer; Kennedy, Emma; Pai, Madhavi; Bain, Earle; Lassman, Andrew B; Moazami, Golnaz.
Affiliation
  • Vize CJ; Department of Ophthalmology, Hull University Teaching Hospitals NHS Trust, Hull, UK.
  • Kim SK; Department of Ophthalmology and Visual Science, University of Texas McGovern Medical School, Houston, Texas, USA.
  • Matthews T; Birmingham Neuro-Ophthalmology Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Macsai M; Northshore University Health System, Glenview, Illinois, USA.
  • Merrell R; NorthShore University Health System, Evanston, Illinois, USA.
  • Hsu S; The Vivian L. Smith Department of Neurosurgery, University of Texas McGovern Medical School, Houston, Texas, USA.
  • Kundu MG; AbbVie, North Chicago, Illinois, USA.
  • Yoon J; AbbVie, North Chicago, Illinois, USA.
  • Kennedy E; AbbVie, North Chicago, Illinois, USA.
  • Pai M; AbbVie, North Chicago, Illinois, USA.
  • Bain E; AbbVie, North Chicago, Illinois, USA.
  • Lassman AB; Division of Neuro-Oncology, Department of Neurology and the Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian, New York, New York, USA.
  • Moazami G; Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA.
Ophthalmic Res ; 66(1): 1030-1043, 2023.
Article in En | MEDLINE | ID: mdl-37257422

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Ophthalmic Res Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Ophthalmic Res Year: 2023 Document type: Article Affiliation country: